STUDIES

The main objective of SPOG is patient-oriented paediatric cancer research. The research projects are assigned to three areas:

Patient-related Clinical Research
This area forms the primary focus in SPOG’s dedicated work. This type of research runs in parallel with the treatment of little and young patients according to precisely defined treatment plans at the most up to date medical science. The insights gained from this are documented in a standardised manner and evaluated statistically. This results finally in scientific publications that form medical progress.

SPOG_List_of_Studies_in the_Field_of_Leukaemias_and_Lymphomas_engl_20170920
SPOG_List_of_Studies_solid_Tumors_engl_20170920
SPOG_List_of_Studies_in_the_Field_of_Brain_Tumours_and_Especially_Rare_Paediatric_Cancers_engl_20170920
Early_phase_and_or_targeted_therapy_studies_Switzerland_20171018

Translational Research
This area of research is indispensable, in order to make use of insights from basic research. Within SPOG this kind of research is done on one hand through studies of tissue material from our own biobank. On the other hand, practically all newer studies today include a so-called biological component whereby the tissue and blood samples from the patients, and/or the biological properties of these samples are evaluated so that important decisions about treatment in the sense of risk-adapted treatments can be taken based on this information.

Outcome and Epidemiological Research
These studies engage for example questions about prevention and the patient’s long-term perspectives. Additionally they constantly critically analyse the actual benefit that the target group stands to gain from various preventive and therapeutic measures.

Within SPOG these study projects are carried out by the Swiss Childhood Cancer Registry. The registry is a member institution of the SPOG. You can find details about the projects of the Swiss Childhood Cancer Registry on www.childhoodcancerregistry.ch